Zevra Therapeutics (ZVRA) EPS (Basic) (2014 - 2026)
Zevra Therapeutics (ZVRA) posted EPS (Basic) of $0.65 for Q1 2026, up 194.96% on a QoQ basis from $0.22 in Q4 2025, and up 1232.43% year-over-year from $0.05 in Q1 2025.
Zevra Therapeutics (ZVRA) EPS (Basic) (2014 - 2026) Analysis & Trends
Zevra Therapeutics' EPS (Basic) history runs 13 years deep, the most recent figure standing at $0.65 for Q1 2026.
- Quarterly EPS (Basic) rose 1232.43% year-over-year to $0.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.13 (up 225.07% YoY) and the FY2025 annual result came in at $1.5, up 165.96% from the prior year.
- EPS (Basic) was $0.65 for Q1 2026 at Zevra Therapeutics, up from $0.22 in the prior quarter.
- Across five years, EPS (Basic) topped out at $1.36 in Q2 2025 and bottomed at -$0.77 in Q4 2024.
- A 5-year average of -$0.16 and a median of -$0.26 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) plunged 532.01% — and 2026, when it surged 1232.43%.
- Zevra Therapeutics' EPS (Basic) stood at -$0.26 in 2022, then tumbled by 114.52% to -$0.56 in 2023, then slumped by 37.72% to -$0.77 in 2024, then surged by 128.46% to $0.22 in 2025, then jumped by 194.96% to $0.65 in 2026.
- Business Quant data shows ZVRA's EPS (Basic) at $0.65 in Q1 2026, $0.22 in Q4 2025, and -$0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 0.65 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.65 |
| Dec 31, 2025 | 0.22 |
| Sep 30, 2025 | -0.01 |
| Jun 30, 2025 | 1.36 |
| Mar 31, 2025 | -0.06 |
| Dec 31, 2024 | -0.77 |
| Sep 30, 2024 | -0.69 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | -0.40 |
| Dec 31, 2023 | -0.56 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -0.34 |
| Dec 31, 2022 | -0.26 |
| Sep 30, 2022 | -0.19 |
| Jun 30, 2022 | -0.70 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.09 |
| Sep 30, 2021 | -0.05 |
| Jun 30, 2021 | -0.37 |